What qualifications should a psilocybin facilitator have?

A qualified psilocybin facilitator should have formal training in psychedelic-assisted therapy or facilitation, first aid and CPR certification, a background in mental health support or a related field, and practical supervised experience. In jurisdictions with regulated programs (such as Oregon), state licensure is also required.

Is there a certification for psilocybin therapy practitioners?

Yes. Oregon's Psilocybin Services program requires facilitators to complete a state-approved training program and obtain a license. Several training organizations—including the Multidisciplinary Association for Psychedelic Studies (MAPS) and the California Institute of Integral Studies—also offer certificate programs in psychedelic-assisted therapy.

What does a psilocybin facilitator certification involve?

Facilitator certification programs typically include coursework in psychedelic pharmacology, trauma-informed care, ethical guidelines, session preparation and integration, and crisis intervention. Most programs also require supervised practicum hours where trainees support real sessions under mentor oversight.

Why is professional training important for psilocybin-assisted therapy?

Trained facilitators are equipped to screen participants for contraindications, establish safe set and setting, recognize and respond to psychological crises, and support meaningful integration after a session. Without proper training, facilitators may inadvertently escalate distress or miss warning signs of a medical emergency.

✅ Trip Sitter Readiness Checklist

Sitting for someone is a serious responsibility. You are the designated driver of their consciousness. Use this self-assessment to ensure you are prepared. Work through each group honestly — do not rush to check boxes before you can answer each item with genuine confidence.

🧠 Knowledge & Understanding

Substance Knowledge: I know the dosage, duration, and expected effects of the specific substance being used. I can describe the typical onset window (20–60 minutes for psilocybin mushrooms), the peak (2–3 hours), and the full duration (4–6 hours) with clarity.

Emergency Protocols: I know when to call for medical help (seizures, unresponsiveness, sustained loss of contact) vs. when psychological distress can be held safely within the session. I have reviewed the clinical criteria that distinguish panic from genuine medical emergency.

Drug Interactions Knowledge: I have confirmed that the voyager is not taking SSRIs, MAOIs, lithium, tramadol, or other medications with known interactions with serotonergic substances. I understand that MAOIs combined with psilocybin can cause unpredictably intense and dangerous effects, and that lithium raises seizure risk.

Personal Experience Requirement: I have personally experienced the substance at a comparable or higher dose before taking on a sitter role. Sitting for someone through an experience you have never had yourself introduces avoidable blind spots in empathy and situational judgment.

Medical Screening Ability: I have asked the voyager about their personal and family history of psychosis, bipolar disorder type I, and active suicidality. I understand that these conditions represent significant contraindications and that my role is not to override medical advice.

Integration Support Knowledge: I understand that the experience does not end when the effects wear off. I am prepared to check in with the voyager in the days following the session, and I know what integration support looks like: reflective conversation, journaling encouragement, and referral to a therapist if difficult material has surfaced.

🧘 Emotional Stability

Calm Presence: I can remain calm even if the voyager is screaming, crying, or panicking. I have practiced or experienced staying regulated under emotional pressure in other contexts — caregiving, crisis support, or intensive personal work.

Non-Judgmental: I am prepared to witness vulnerable moments without judgment or interference. This includes sexual content, regressive behavior, spiritual declarations, and expressions of grief or rage that may feel uncomfortable to observe.

Trauma Awareness: I understand that psilocybin can surface repressed memories and traumatic material. I am not startled by sudden emotional intensity, and I know that my role in these moments is to hold steady — not to problem-solve, reframe, or minimize what is arising.

Self-Reflection Practice: I have an active practice — whether meditation, journaling, therapy, or somatic bodywork — that allows me to process my own emotional material between sessions. Sitters who are carrying unresolved personal distress are at risk of projecting it onto the voyager or being triggered by the session's content.

Boundary Clarity: I have explicit, pre-agreed boundaries with the voyager about physical contact, verbal interruption, and the limits of my role. I understand that a psychedelic state increases suggestibility and emotional openness, and that it is my responsibility — not the voyager's — to hold those boundaries throughout the session.

🎒 Practical Preparation

Time Commitment: I have cleared my schedule for the entire duration (6–8 hours) plus a 2-hour buffer. I have arranged childcare, pet care, or any other obligations that could pull me away from the space during the session.

Supplies: I have water, blankets, tissues, a curated playlist, and a bucket (in case of nausea) ready before the session begins. I am not improvising logistics during the experience itself.

Safe Space Setup: The physical environment has been prepared in advance. The space is private, comfortable, and unlikely to be interrupted by unexpected visitors. Locks are accessible, lighting can be adjusted, and the temperature is controllable. Sharp objects or anything that could pose a risk during disorientation have been removed or secured.

Emergency Numbers Confirmed: I have the local emergency services number, the address of the nearest hospital, and a harm reduction crisis line (such as the FIRESIDE Project in the US: 62-FIRESIDE) saved and accessible. I know the nearest route to emergency care by vehicle.

Integration Plan Ready: The voyager and I have discussed what happens after the session. There is a plan for the rest of the day — no driving, no difficult social obligations — and a tentative check-in call or meeting scheduled for 24–72 hours later.

Medical History Reviewed: I have had an honest pre-session conversation with the voyager about their full medical and psychiatric history, current medications, recreational drug use, and any history of adverse reactions to psychedelics. Nothing in that history was brushed past because it was uncomfortable to discuss.

🔬 Pharmacology Knowledge

Onset, Peak, and Duration Windows: I can accurately describe the time course of psilocybin mushrooms — onset typically 20–60 minutes after ingestion, peak effects between 2 and 3 hours, gradual return to baseline by 4–6 hours. I understand that food intake slows onset and that "redosing" during a plateau rarely adds to the experience but can unpredictably extend it.

Dose Ranges and Effect Profiles: I understand the rough correspondence between dose and effect: threshold effects at 0.5–1g of dried mushrooms, moderate perceptual changes at 1–2g, strong psychedelic effects at 2–3.5g, and high-dose ego-dissolution territory above 4g. I do not treat these numbers as precise — individual variation, potency differences between batches, and set and setting all modulate the response significantly.

Tolerance and Cross-Tolerance: I know that psilocybin produces rapid tachyphylaxis (tolerance) — repeating a session within a few days will produce markedly reduced effects. I also know that cross-tolerance exists with other classic psychedelics (LSD, mescaline, DMT), and that this is relevant when a voyager discloses recent use of another substance in the same class.

Psychological vs. Medical Emergencies: I can distinguish between a psychological crisis (extreme fear, paranoia, thought loops, emotional overwhelm — distressing but not medically dangerous) and a genuine medical emergency (sustained loss of consciousness, seizure activity, blue lips or fingertips indicating oxygen deprivation, chest pain radiating to jaw or arm). The former calls for sitter presence and grounding; the latter calls for emergency services.

🧭 Ethical Readiness

No Substance Impairment: I will be completely sober throughout the session. I will not use cannabis, alcohol, or any other psychoactive substance before or during my sitter role, even in small amounts. Impairment reduces my capacity to make accurate situational judgments at the moments they most matter.

No Romantic or Financial Interest: I do not have a romantic, sexual, or financial interest in the voyager that could compromise my neutrality during the session. I understand that psychedelics increase emotional vulnerability and that exploiting this vulnerability — even subtly — constitutes a serious ethical violation, regardless of intent.

Confidentiality Understood: I have a clear understanding with the voyager about what information from the session I will and will not share with others. I treat what arises during the session — visions, confessions, emotional disclosures — with the same discretion I would expect in a therapeutic relationship. Nothing is shared without explicit permission.

Commitment to Non-Directive Support: I understand that my job is to support the voyager's process, not to guide it toward outcomes I think are useful or meaningful. I will not suggest spiritual interpretations, prompt specific memories, or steer the emotional content of the session. My role is to hold the space, not to shape what fills it.

Why These Standards Matter

Informal trip sitting exists in a space between friendship and facilitation — it carries real ethical weight without the institutional accountability structures that professional therapists operate within. This is not a reason to avoid it, but it is a reason to take it seriously. The absence of a license does not mean the absence of responsibility. When you agree to sit for someone, you are taking on the duty of care for their physical safety and emotional wellbeing during one of the most vulnerable states a human being can enter voluntarily.

Research into psychedelic-assisted therapy consistently shows that adverse outcomes — lasting psychological distress, acute psychiatric decompensation, or trauma — are far more common in unsupported settings than in sessions with a competent, present sitter. A 2016 survey of over 1,200 psilocybin users published in the Journal of Psychopharmacology found that the most commonly cited protective factor in difficult experiences was the presence of a calm, trusted person. Conversely, being alone, in an unfamiliar setting, or with a sitter who panicked were among the most consistently cited risk factors. Your readiness is not a bureaucratic formality — it is a direct harm-reduction variable.

Completing this checklist is a starting point, not a credential. There is no certification that fully prepares a person for the range of experiences that can arise during a high-dose psilocybin session. Experienced facilitators with hundreds of sessions behind them still encounter moments of uncertainty and difficulty. What separates an effective sitter from an ineffective one is not the absence of challenge — it is the capacity to remain regulated, present, and non-reactive when challenge arrives. This checklist is designed to help you honestly assess whether you are at a starting baseline for that capacity. If any item gives you pause, treat that pause as information worth taking seriously before you commit to sitting for someone else.